Synthetic Cannabinoids Global Market Report 2025

Description

Synthetic cannabinoids are laboratory-engineered compounds designed to replicate the effects of natural cannabinoids by binding to cannabinoid receptors in the body. These compounds are produced through advanced chemical synthesis and can be much more potent and unpredictable than their natural counterparts. Some synthetic cannabinoids are also used in regulated pharmaceutical applications for therapeutic purposes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of synthetic cannabinoids include high-pure synthetic cannabinoids and ultra-pure synthetic cannabinoids. High-pure synthetic cannabinoids are chemically engineered compounds that replicate the effects of natural cannabinoids, such as tetrahydrocannabinol (THC), found in the cannabis plant. These cannabinoids are available in various formulations, including oils, capsules, edibles, vapes, and topicals, and are used for several indications, such as pain management, nausea and vomiting relief, and the treatment of neurological disorders. They are distributed through different channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are used in applications such as pharmaceuticals, research, recreational use, agriculture, and nutraceuticals.

The synthetic cannabinoids market research report is one of a series of new reports from The Business Research Company that provides synthetic cannabinoids market statistics, including synthetic cannabinoids industry global market size, regional shares, competitors with a synthetic cannabinoids market share, detailed synthetic cannabinoids market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic cannabinoids industry. This synthetic cannabinoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The synthetic cannabinoids market size has grown rapidly in recent years. It will grow from$1.88 billion in 2024 to $2.22 billion in 2025 at a compound annual growth rate (CAGR) of 18.3%. The growth during the historic period can be attributed to several factors, including the rising demand for alternative drugs, an increasing number of cannabis users, expanding pharmaceutical applications, growing demand for legal highs, and a shift towards self-medication.

The synthetic cannabinoids market size is expected to see rapid growth in the next few years. It will grow to$4.30 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth during the forecast period can be attributed to several factors, including the rising popularity of designer drugs, the growing legalization of cannabis, increased online accessibility of synthetic drugs, the growing popularity of vaping, and the rising customization of cannabinoid products. Key trends during this period include advanced forensic toxicology techniques, machine learning for chemical pattern recognition, cloud-based illicit drug tracking, innovations in synthetic cannabinoid formulations, and the development of novel cannabinoid analogs.

The growing demand for treatments of neurological disorders is expected to drive the expansion of the synthetic cannabinoids market. Neurological disorders, which affect the brain, spinal cord, and nerves, can disrupt movement, sensation, cognition, and overall bodily functions. The rise in neurological conditions is largely attributed to the aging global population, as diseases such as Alzheimer's become more prevalent with age, due to the natural aging of the brain and accumulated cellular damage. Synthetic cannabinoids work by interacting with cannabinoid receptors in the brain, which helps regulate neurotransmitter activity and may assist in alleviating symptoms related to neurological disorders. For example, in September 2024, the European Brain Council, based in Belgium, reported that 7 million people in Europe are currently living with Alzheimer's disease. This number is expected to double to 14 million by 2030, due to the aging population, posing a significant global public health issue. As a result, the increasing demand for treatments for neurological disorders is driving the growth of the synthetic cannabinoids market.

Leading companies in the synthetic cannabinoids market are focusing on developing advanced technologies, such as fungal expression systems, to improve production efficiency and reduce costs. Fungal expression systems involve genetically engineered fungi that biosynthesize synthetic cannabinoids, offering a sustainable and scalable alternative to traditional chemical synthesis or plant extraction methods. These systems enable the production of high-purity cannabinoids for pharmaceutical and research applications. For example, in January 2022, Dyadic International Inc., a biotechnology company based in the US, introduced its C1-cell protein production platform to manufacture synthetic cannabinoids. This innovative approach utilizes filamentous fungal cell factories to produce cannabinoids such as cannabidiol (CBD) and its precursors in a more cost-effective and sustainable manner. The process is environmentally friendly, energy-efficient, and capable of yielding purer cannabinoids that meet regulatory standards, with potential therapeutic uses in treating chronic pain, inflammation, and other medical conditions.

In January 2022, Dermapharm Holding SE, a Germany-based pharmaceutical manufacturer, acquired C3 Cannabinoid Compound Company GmbH for $87.35 million. With this acquisition, Dermapharm Holding SE aims to bolster its position as a leader in the medical cannabis market, expand into new European regions, and leverage synergies to improve patient access while driving growth in cannabinoid-based pharmaceuticals. C3 Cannabinoid Compound Company GmbH, based in Germany, specializes in the production of synthetic cannabinoids.

Major players in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., and Canntab Therapeutics Ltd.

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in synthetic cannabinoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the synthetic cannabinoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The synthetic cannabinoids market consists of sales of research chemicals, prescription medications, and herbal incense products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Cannabinoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on synthetic cannabinoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic cannabinoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The synthetic cannabinoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: High-Pure Synthetic Cannabinoids; Ultra-Pure Synthetic Cannabinoids
2) By Formulation: Oil; Capsules; Edibles; Vapes; Topicals
3) By Indication: Pain Management; Nausea Or Vomiting; Neurological Disorder Management; Other Indications
4) By Application: Pharmaceuticals; Research; Recreational Use; Agriculture; Nutraceuticals
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids; Research-Grade Cannabinoids; Industrial-Use Cannabinoids
2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids; Biotechnology-Grade Cannabinoids; Analytical-Standard Cannabinoids
Companies Mentioned: Johnson Matthey; Harmony Biosciences; BioVectra; Restek Corporation; Noramco Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34988

1. Executive Summary

2. Synthetic Cannabinoids Market Characteristics

3. Synthetic Cannabinoids Market Trends And Strategies

4. Synthetic Cannabinoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Synthetic Cannabinoids Growth Analysis And Strategic Analysis Framework

5.1. Global Synthetic Cannabinoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Synthetic Cannabinoids Market Growth Rate Analysis
5.4. Global Synthetic Cannabinoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Synthetic Cannabinoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Synthetic Cannabinoids Total Addressable Market (TAM)

6. Synthetic Cannabinoids Market Segmentation

6.1. Global Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-Pure Synthetic Cannabinoids
Ultra-Pure Synthetic Cannabinoids
6.2. Global Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oil
Capsules
Edibles
Vapes
Topicals
6.3. Global Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Nausea Or Vomiting
Neurological Disorder Management
Other Indications
6.4. Global Synthetic Cannabinoids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Synthetic Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Research
Recreational Use
Agriculture
Nutraceuticals
6.6. Global Synthetic Cannabinoids Market, Sub-Segmentation Of High-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical-Grade Cannabinoids
Research-Grade Cannabinoids
Industrial-Use Cannabinoids
6.7. Global Synthetic Cannabinoids Market, Sub-Segmentation Of Ultra-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical-Grade Cannabinoids
Biotechnology-Grade Cannabinoids
Analytical-Standard Cannabinoids

7. Synthetic Cannabinoids Market Regional And Country Analysis

7.1. Global Synthetic Cannabinoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Synthetic Cannabinoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Synthetic Cannabinoids Market

8.1. Asia-Pacific Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Synthetic Cannabinoids Market

9.1. China Synthetic Cannabinoids Market Overview
9.2. China Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Synthetic Cannabinoids Market

10.1. India Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Synthetic Cannabinoids Market

11.1. Japan Synthetic Cannabinoids Market Overview
11.2. Japan Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Synthetic Cannabinoids Market

12.1. Australia Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Synthetic Cannabinoids Market

13.1. Indonesia Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Synthetic Cannabinoids Market

14.1. South Korea Synthetic Cannabinoids Market Overview
14.2. South Korea Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Synthetic Cannabinoids Market

15.1. Western Europe Synthetic Cannabinoids Market Overview
15.2. Western Europe Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Synthetic Cannabinoids Market

16.1. UK Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Synthetic Cannabinoids Market

17.1. Germany Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Synthetic Cannabinoids Market

18.1. France Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Synthetic Cannabinoids Market

19.1. Italy Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Synthetic Cannabinoids Market

20.1. Spain Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Synthetic Cannabinoids Market

21.1. Eastern Europe Synthetic Cannabinoids Market Overview
21.2. Eastern Europe Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Synthetic Cannabinoids Market

22.1. Russia Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Synthetic Cannabinoids Market

23.1. North America Synthetic Cannabinoids Market Overview
23.2. North America Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Synthetic Cannabinoids Market

24.1. USA Synthetic Cannabinoids Market Overview
24.2. USA Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Synthetic Cannabinoids Market

25.1. Canada Synthetic Cannabinoids Market Overview
25.2. Canada Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Synthetic Cannabinoids Market

26.1. South America Synthetic Cannabinoids Market Overview
26.2. South America Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Synthetic Cannabinoids Market

27.1. Brazil Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Synthetic Cannabinoids Market

28.1. Middle East Synthetic Cannabinoids Market Overview
28.2. Middle East Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Synthetic Cannabinoids Market

29.1. Africa Synthetic Cannabinoids Market Overview
29.2. Africa Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Synthetic Cannabinoids Market Competitive Landscape And Company Profiles

30.1. Synthetic Cannabinoids Market Competitive Landscape
30.2. Synthetic Cannabinoids Market Company Profiles
- 30.2.1. Johnson Matthey Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Harmony Biosciences Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. BioVectra Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Restek Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Noramco Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Synthetic Cannabinoids Market Other Major And Innovative Companies

31.1. Cayman Chemical
31.2. Cerilliant Corporation
31.3. Skye Bioscience
31.4. Purisys LLC
31.5. Chiron AS
31.6. Lygos Inc.
31.7. Botanix Pharmaceuticals
31.8. CB Therapeutics Inc.
31.9. BayMedica
31.10. Zynerba Pharmaceuticals Inc.
31.11. Kannalife Sciences Inc.
31.12. SciSparc Ltd.
- 31.13. 180 Life Science
31.14. Tetra Bio-Pharma Inc
31.15. Canntab Therapeutics Ltd

32. Global Synthetic Cannabinoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Synthetic Cannabinoids Market

34. Recent Developments In The Synthetic Cannabinoids Market

35. Synthetic Cannabinoids Market High Potential Countries, Segments and Strategies

35.1 Synthetic Cannabinoids Market In 2029 - Countries Offering Most New Opportunities
35.2 Synthetic Cannabinoids Market In 2029 - Segments Offering Most New Opportunities
35.3 Synthetic Cannabinoids Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r34988_Synthetic_Cannabinoids_GMR_2025